A bronchial carcinoid tumor is a rare type of neuroendocrine tumor that develops in the cells of the airways, or bronchi. These tumors generally grow more slowly than many other forms of lung cancer, but their behavior can vary depending on the specific type. Bronchial carcinoid tumors can occur in people of different ages and are sometimes discovered unexpectedly during investigations for respiratory symptoms.

The two major types are typical carcinoid and atypical carcinoid. Accurate diagnosis is important because the treatment and follow-up approach depend on the tumor type, size, location and whether it has spread to lymph nodes or other parts of the body.

What Is a Bronchial Carcinoid Tumor?

Bronchial carcinoid tumors arise from neuroendocrine cells in the respiratory tract. These cells have specialized functions and can produce hormones or hormone-like substances.

Unlike many conventional lung cancers, carcinoid tumors often grow relatively slowly. However, atypical carcinoid tumors tend to behave more aggressively than typical carcinoids and have a greater likelihood of spreading.

Bronchial carcinoids are classified into:

• Typical carcinoid: Generally slower growing and less likely to spread.

• Atypical carcinoid: Less common and associated with a higher risk of lymph-node involvement and metastasis.

Because these tumors can occur inside or close to the airways, even a relatively small tumor can cause significant respiratory symptoms by partially blocking an airway.

Symptoms of Bronchial Carcinoid Tumor

Some bronchial carcinoid tumors cause no symptoms and are discovered incidentally during a chest X-ray or CT scan. When symptoms occur, they can sometimes resemble common respiratory illnesses.

Possible symptoms include:

• Persistent or recurrent cough

• Wheezing

• Shortness of breath

• Recurrent pneumonia or chest infections

• Coughing up blood, known as hemoptysis

• Chest discomfort

• Recurrent symptoms affecting the same area of the lung

• Unexplained respiratory symptoms

Because bronchial carcinoid tumors may grow within the airway, repeated episodes of pneumonia or unexplained localized lung collapse can sometimes lead doctors to investigate for an obstructing lesion.

Carcinoid Syndrome

Some neuroendocrine tumors can release biologically active substances into the bloodstream. When this causes a characteristic group of symptoms, it is referred to as carcinoid syndrome.

Symptoms may include facial flushing, diarrhea, wheezing and rapid heartbeat. Carcinoid syndrome is relatively uncommon with primary bronchial carcinoid tumors but may occur in certain patients, particularly when there is significant hormone secretion or metastatic disease.

Patients with possible hormone-related symptoms require appropriate biochemical and clinical evaluation.

Risk Factors

The exact cause of most bronchial carcinoid tumors is not known. Unlike many conventional lung cancers, they are not strongly associated with cigarette smoking.

Some neuroendocrine tumors may be associated with inherited conditions. For example, multiple endocrine neoplasia type 1 (MEN1) can increase the risk of certain neuroendocrine tumors.

Most patients with bronchial carcinoid tumors, however, do not have a clearly identifiable cause or inherited risk factor.

How Is a Bronchial Carcinoid Tumor Diagnosed?

Diagnosis usually begins with imaging. A chest CT scan can show the location, size and characteristics of a suspected tumor and can also identify enlarged lymph nodes.

Because bronchial carcinoids often arise within the airways, bronchial carcinoid tumor is an important diagnostic procedure. During bronchoscopy, a pulmonologist or interventional pulmonologist can directly examine the airways and, when appropriate, obtain tissue for pathological examination.

The biopsy is examined by a pathologist to determine whether the lesion is a carcinoid tumor and whether it has features of a typical or atypical carcinoid.

Additional imaging, such as PET/CT or specialized functional imaging, may be recommended in selected patients to evaluate the tumor and look for possible spread.

Role of Bronchoscopy and EBUS

Bronchoscopy can provide valuable information about the tumor's appearance, airway involvement and exact location. It can also allow tissue sampling.

When lymph nodes in the chest are enlarged or require evaluation, endobronchial ultrasound (EBUS) may be used to obtain samples from mediastinal or hilar lymph nodes.

EBUS-guided sampling can help determine whether the tumor has spread to nearby lymph nodes and can contribute to treatment planning in appropriately selected patients.

Treatment of Bronchial Carcinoid Tumors

Treatment depends on several factors, including the tumor type, size, location, lymph-node involvement, presence of distant disease and the patient's overall health.

Surgery

Surgical removal is the preferred treatment for many localized bronchial carcinoid tumors. The goal is to completely remove the tumor while preserving as much healthy lung tissue as possible.

Depending on the location and characteristics of the tumor, surgical options may include a limited lung resection, sleeve resection, lobectomy or another appropriate procedure.

The specific operation is determined by a thoracic surgeon after reviewing imaging, bronchoscopy and pathology findings.

Endobronchial Treatment

For selected small, centrally located tumors, bronchial carcinoid tumor may be considered. Techniques such as bronchoscopic resection, laser therapy, electrocautery or other modalities can sometimes be used in carefully selected situations.

These approaches are not appropriate for every carcinoid tumor. The decision depends on tumor size, depth of invasion, location and whether there is evidence of lymph-node or distant spread.

Treatment for Advanced Disease

If a carcinoid tumor has spread to lymph nodes or distant organs, management becomes more complex. Treatment options can include surgery in selected cases, somatostatin analogues, peptide receptor radionuclide therapy, targeted approaches or other systemic treatments depending on tumor characteristics.

A multidisciplinary neuroendocrine or thoracic oncology team can help determine the most appropriate strategy.

Prognosis and Follow-Up

The prognosis of bronchial carcinoid tumors is often favorable, particularly for typical carcinoid tumors that are diagnosed early and completely removed. Atypical carcinoids have a greater risk of recurrence and metastatic spread.

Long-term follow-up is important because recurrence can occur years after the initial treatment. Follow-up may include clinical assessment and periodic imaging based on the tumor type, stage and treatment history.

When Should You See a Specialist?

Persistent cough, recurrent pneumonia, unexplained wheezing, coughing up blood or an abnormal lung lesion on imaging should be evaluated by a qualified medical professional.

If a CT scan shows a suspected endobronchial or bronchial tumor, consultation with an experienced pulmonologist or interventional pulmonologist may help determine whether bronchoscopy, EBUS or another diagnostic procedure is appropriate.